Amicus Therapeutics
FOLD
$10.28
Share price
1.08%
Change (1 day)
-10.92%
Change (1 year)
Categories
Amicus Therapeutics (FOLD) - Total liabilities
Total liabilities on the balance sheet as of December 2023 : $0.61 B
According to Amicus Therapeutics 's latest financial reports the company's total liabilities are $0.61 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Amicus Therapeutics - Total liabilities on balance sheet (from 2005 to 2023)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | $0.61 B | 2.76% |
| 2022-12-31 | $0.60 B | 0.56% |
| 2021-12-31 | $0.59 B | -0.39% |
| 2020-12-31 | $0.60 B | 60.56% |
| 2019-12-31 | $0.37 B | -16.39% |
| 2018-12-31 | $0.44 B | 63.05% |
| 2017-12-31 | $0.27 B | -59.48% |
| 2016-12-31 | $0.67 B | 20.72% |
| 2015-12-31 | $0.56 B | 538.52% |
| 2014-12-31 | $87.78 M | 7.31% |
| 2013-12-31 | $81.81 M | 100.19% |
| 2012-12-31 | $40.86 M | 1.65% |
| 2011-12-31 | $40.2 M | -15.57% |
| 2010-12-31 | $47.61 M | 251.76% |
| 2009-12-31 | $13.53 M | -76.55% |
| 2008-12-31 | $57.73 M | -9.51% |
| 2007-12-31 | $63.8 M | -53.48% |
| 2006-12-31 | $0.13 B | 112.65% |
| 2005-12-31 | $64.49 M | |
| 2003-12-31 | $5.77 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Novo Nordisk NVO | $30.79 B | 4,885.25% | 🇩🇰 Denmark |
 Biogen BIIB | $11.35 B | 1,738.19% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $58.82 B | 9,423.19% | 🇬🇧 UK |
 Lexicon Pharmaceuticals
LXRX | $0.13 B | -77.93% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | $0.66 B | 6.97% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $1.89 B | 205.98% | 🇺🇸 USA |